Literature DB >> 19549172

Comparative in vivo and in vitro analyses of putative virulence factors of Burkholderia pseudomallei using lipopolysaccharide, capsule and flagellin mutants.

Chanthiwa Wikraiphat1, Jaruek Charoensap, Pongsak Utaisincharoen, Surasakdi Wongratanacheewin, Suwimol Taweechaisupapong, Donald E Woods, Jan G M Bolscher, Stitaya Sirisinha.   

Abstract

Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis. We evaluated host-pathogen interaction at different levels using three separate B. pseudomallei mutants generated by insertional inactivation. One of these mutants is defective in the production of the polysaccharide side chains associated with lipopolysaccharide; one does not produce the capsular polysaccharide with the structure -3)-2-O-acetyl-6-deoxy-beta-d-manno-heptopyranose-(1-; and the third mutant does not produce flagellin. We compared the in vivo virulence in BALB/c mice, the in vitro fate of intracellular survival inside human polymorphonuclear cells (PMNs) and macrophages (Mphis) and the susceptibility to killing by 30% normal human serum, reactive nitrogen and oxygen intermediates and antimicrobial peptides with that of their wild-type counterpart. The lipopolysaccharide and capsule mutants demonstrated a marked reduction in virulence for BALB/c mice, but the flagellin mutant was only slightly less virulent than the parent strain. The results from the BALB/c mice experiments correlated with survival in Mphis. The lipopolysaccharide and capsule mutants were also more susceptible to killing by antimicrobial agents. All bacteria were equally susceptible to killing by PMNs. Altogether, the data suggest that lipopolysaccharide and capsule and, to a much lesser extent, flagella, are most likely associated with the virulence of this bacterium and highlight the importance of intracellular killing by PMNs and Mphis in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549172     DOI: 10.1111/j.1574-695X.2009.00574.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  24 in total

1.  Role of Toll-Like Receptor 5 (TLR5) in Experimental Melioidosis.

Authors:  Emma Birnie; Tassili A F Weehuizen; Jacqueline M Lankelma; Hanna K de Jong; Gavin C K W Koh; Miriam H P van Lieshout; Joris J T H Roelofs; Andries E Budding; Alex F de Vos; Tom van der Poll; W Joost Wiersinga
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

2.  Sterile-α- and armadillo motif-containing protein inhibits the TRIF-dependent downregulation of signal regulatory protein α to interfere with intracellular bacterial elimination in Burkholderia pseudomallei-infected mouse macrophages.

Authors:  Pankaj Baral; Pongsak Utaisincharoen
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

3.  Characterization of New Virulence Factors Involved in the Intracellular Growth and Survival of Burkholderia pseudomallei.

Authors:  Madeleine G Moule; Natasha Spink; Sam Willcocks; Jiali Lim; José Afonso Guerra-Assunção; Felipe Cia; Olivia L Champion; Nicola J Senior; Helen S Atkins; Taane Clark; Gregory J Bancroft; Jon Cuccui; Brendan W Wren
Journal:  Infect Immun       Date:  2015-12-28       Impact factor: 3.441

4.  Flagellar glycosylation in Burkholderia pseudomallei and Burkholderia thailandensis.

Authors:  Andrew E Scott; Susan M Twine; Kelly M Fulton; Richard W Titball; Angela E Essex-Lopresti; Timothy P Atkins; Joann L Prior
Journal:  J Bacteriol       Date:  2011-05-20       Impact factor: 3.490

5.  Dictyostelium discoideum as a model system for identification of Burkholderia pseudomallei virulence factors.

Authors:  Benjamin M Hasselbring; Maharsh K Patel; Mark A Schell
Journal:  Infect Immun       Date:  2011-03-14       Impact factor: 3.441

6.  Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region.

Authors:  Jon Cuccui; Timothy S Milne; Nicholas Harmer; Alison J George; Sarah V Harding; Rachel E Dean; Andrew E Scott; Mitali Sarkar-Tyson; Brendan W Wren; Richard W Titball; Joann L Prior
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

7.  Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells.

Authors:  Samantha J Dando; Deepak S Ipe; Michael Batzloff; Matthew J Sullivan; David K Crossman; Michael Crowley; Emily Strong; Stephanie Kyan; Sophie Y Leclercq; Jenny A K Ekberg; James St John; Ifor R Beacham; Glen C Ulett
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

8.  Contribution of murine IgG Fc regions to antibody binding to the capsule of Burkholderia pseudomallei.

Authors:  Michael J Dillon; Rachael A Loban; Dana E Reed; Peter Thorkildson; Kathryn J Pflughoeft; Sujata G Pandit; Paul J Brett; Mary N Burtnick; David P AuCoin
Journal:  Virulence       Date:  2016-04-20       Impact factor: 5.882

9.  Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis.

Authors:  Jonathan M Warawa; Dan Long; Rebecca Rosenke; Don Gardner; Frank C Gherardini
Journal:  Infect Immun       Date:  2009-09-14       Impact factor: 3.441

10.  Burkholderia pseudomallei induces IL-23 production in primary human monocytes.

Authors:  Panthong Kulsantiwong; Matsayapan Pudla; Jitrada Boondit; Chanthiwa Wikraiphat; Susanna J Dunachie; Narisara Chantratita; Pongsak Utaisincharoen
Journal:  Med Microbiol Immunol       Date:  2015-11-12       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.